EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ixekizumab, An Effective Biologic Agent Therapy in Various Cases of Psoriasis: A Narrative Review

Nanda Daiva Putra, Sylvia Anggraeni

Journal of Pakistan Association of Dermatologists · 30.06.2025 · 35 (2) · 152-157

DOI: 10.66344/jpad.v35i2.2868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pakistan Association of Dermatologists, online erschienen am 30.06.2025. Verfasst von Nanda Daiva Putra und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic inflammatory skin condition with immune involvement, characterized by skin inflammation and epidermal hyperplasia, increased risk of arthritis, cardiovascular disorders, and psychosocial burden. In the current management of psoriasis, the use of biologic therapy is increasingly being studied. This paper is aimed to increase understanding of ixekizumab in psoriasis management, so that its utilization can be optimized. Currently, the main biological agents have action on two crucial pathways in the psoriasis development and its chronicity, namely the IL-23/Th17 pathway and the TNF-? signaling pathway. Biological agents targeting the IL-17 receptor have shown higher efficacy and safety compared to those targeting TNF-? and IL-23 receptors in treating moderate to severe plaque-type psoriasis. Ixekizumab, one of the selective IL-17A pathway inhibitor, plays a crucial role in managing the occurrence of psoriasis. FDA has approved the use of ixekizumab for moderate to severe psoriasis (PsO) and psoriatic arthritis (PsA) . Numerous clinical trials have demonstrated the safety and efficacy of ixekizumab in treating both plaque psoriasis and PsA. The side effects are generally mild, in the form of nasopharyngitis, pain at the injection site, and upper respiratory tract infections.

Zitieren

APA

Putra, N. D., & Anggraeni, S. (2025). Ixekizumab, An Effective Biologic Agent Therapy in Various Cases of Psoriasis: A Narrative Review. Journal of Pakistan Association of Dermatologists, 35(2), 152-157. https://doi.org/10.66344/jpad.v35i2.2868

Vancouver

Putra ND, Anggraeni S. Ixekizumab, An Effective Biologic Agent Therapy in Various Cases of Psoriasis: A Narrative Review. Journal of Pakistan Association of Dermatologists. 2025;35(2):152-157. doi:10.66344/jpad.v35i2.2868

BibTeX
@article{Putra2025,
  author = {Putra, Nanda Daiva and Anggraeni, Sylvia},
  title = {Ixekizumab, An Effective Biologic Agent Therapy in Various Cases of Psoriasis: A Narrative Review},
  journal = {Journal of Pakistan Association of Dermatologists},
  year = {2025},
  volume = {35},
  number = {2},
  pages = {152--157},
  doi = {10.66344/jpad.v35i2.2868}
}
Kostenlos starten →